Rigel Pharmaceuticals Inc. (RIGL)
NASDAQ: RIGLHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 47.32 -1.40%
RIGL stock chart
Technical analysisKey statistics
All statistics- Market cap
- $896.45M
- P/E (TTM)
- 2.84
- Forward P/E
- 9.72
- EPS (TTM)
- $16.88
- Dividend yield
- None
- 52-week range
- 24.95 – 52.24
- Day range
- 45.22 – 48.15
- Volume / Avg
- 232.58K / 291.93K
- Beta
- —
- Shares outstanding
- 18.68M
- Next earnings
- Nov 3, 2026
52-week range
RIGL stock today
On Oct 7, RIGL ended the session at $47.99, adding $1.88 (4.08%), versus the S&P 500's 0.22% decline. At this level, RIGL sits near the top of its 52-week range of $24.95 to $52.24: 8.1% below the high, set on Nov 28, 2025 and 92.3% above the low. RIGL is up 12.0% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 62.7%.
Rigel Pharmaceuticals trades at 2.8x its trailing twelve-month earnings per share of $16.88. Its forward P/E of 9.7x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. Rigel Pharmaceuticals's next earnings report is expected on Nov 3, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Rigel Pharmaceuticals
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2000
Earnings
Earnings history- Next report
- Nov 3, 2026
- EPS estimate
- $0.87
Rigel Pharmaceuticals peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CRVSCorvus Pharmaceuticals Inc. | 10.41 | -1.42% | $875.70M | vs RIGL |
| JBIOJade Biosciences Inc. | 13.77 | +2.68% | $875.74M | vs RIGL |
| ALMSAlumis Inc. | 6.77 | -2.31% | $876.28M | vs RIGL |
| CYRXCryoPort Inc. | 17.35 | -2.53% | $878.76M | vs RIGL |
| ARDXArdelyx Inc. | 3.26 | -1.51% | $841.69M | vs RIGL |
| AVBPArriVent BioPharma Inc. | 16.89 | +11.93% | $832.81M | vs RIGL |
| ANLAdlai Nortye Group Ltd. ADR | 14.05 | -2.84% | $904.79M | vs RIGL |
| OBXObsidian Therapeutics Inc. | 13.20 | -0.15% | $815.40M | vs RIGL |
Indexes, lists and sector
Rigel Pharmaceuticals stock FAQ
What is Rigel Pharmaceuticals's stock price today?
RIGL last traded at $47.99 as of Oct 7, 4:00 PM EDT, up 4.08% on the day. Prices are delayed at least 15 minutes.
Does Rigel Pharmaceuticals pay a dividend?
No. Rigel Pharmaceuticals does not currently pay a regular cash dividend.
When is Rigel Pharmaceuticals's next earnings date?
Rigel Pharmaceuticals is expected to report earnings on Tuesday, November 3, 2026. Analysts expect EPS of $0.87.
What is RIGL's P/E ratio?
RIGL trades at a trailing P/E ratio of 2.84 and a forward P/E of 9.72.
Has RIGL ever split its stock?
Yes. The most recent RIGL stock split was a 1-for-10 split on Jun 27, 2024, one of 2 splits on record.
What is the RIGL 52-week high?
The 52-week high for RIGL is $52.24 and the 52-week low is $24.95. The stock is currently 8.1% below its high.